This report provides exclusive insights into the COVID-19 impact on the Overactive Bladder Treatment Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Overactive Bladder Treatment Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Overactive Bladder Treatment Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on
overactive bladder treatment market provides an in-depth analysis of segments and
sub-segments in the global as well as regional overactive bladder treatment
market. The study also highlights the impact of drivers, restraints, and macro
indicators on the global and regional overactive bladder treatment market over
the short term as well as long term. The report is a comprehensive presentation
of trends, forecast and dollar values of global overactive bladder treatment
market. According to the report, the global overactive bladder treatment market
is projected to grow at a CAGR of 3.1% over the forecast period of 2019-2025.
The global overactive bladder treatment market is expected to gain
promising growth throughout the forecast period. Growing occurrence of overactive
bladder (OAB) along with the growing geriatric population and increasing
prevalence of chronic kidney disease (CKD) are the major factors promoting the
growth of overactive bladder market. As per the National Association for continence,
approximately, 33 million people have an overactive bladder in the USA alone, in
2016. Additionally, the growing development of innovative intravesical
therapies is likely to contribute to market growth. However, low awareness
of overactive bladder treatment among developing countries is expected to
affect the growth of the overactive bladder treatment market. Furthermore,
favorable reimbursements and a number of manufacturers are focusing on research
and the development of novel drugs creates favorable growth opportunities for
the overactive bladder treatment market.
Among the regions, the global overactive bladder treatment market
is segmented into North America, Europe, Asia-Pacific, and RoW. North America
is dominating the global overactive bladder treatment market. The U.S.
dominated the market owing to the well-established healthcare industry. The
factors such as growing elderly population, growing prevalence of chronic
kidney disease (CKD), high incidences of urinary disorders and increasing
number of drugs receiving the FDA approval are responsible for the market
growth in North America. Europe is expected to hold the second position in the
overactive bladder treatment market. This is due to the presence of favorable
government policies regarding the development of health care infrastructure in
Asia-Pacific is expected to
be the fastest-growing region in this market throughout the forecast period.
Additionally, the expansion of pharmaceutical companies and biotech labs in
countries such as China and India have a positive impact on the market in the
Asia-Pacific region. The growth in the geriatric population coupled with rising
per capita health care expenditure is escalating the market in the Asia-Pacific
region. The Middle East and Africa are anticipated to experience steady
growth in the overactive bladder treatment market over the forecast period.
The report on global overactive bladder treatment market covers
segments such as therapy type, and disease type. On the basis of therapy type,
the sub-markets include anticholinergic, solifenacin, fesoterodine, oxybutynin,
mirabegron, darifenacin, boto, and neurostimulation. On the basis of disease
type, the sub-markets include idiopathic bladder overactivity, and neurogenic
The report provides profiles of the companies in the market such
as Medtronic plc, Apotex Inc., Intas Biopharmaceuticals, Johnson & Johnson,
Aurobindo Pharma Limited, Sanofi S.A., Hisamitsu Pharmaceutical Co., Inc., Endo
International plc. Mylan N.V., Allergan plc. and other companies.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical
tools such as Porter's five forces analysis and DRO analysis of overactive
bladder treatment market. Moreover, the study highlights current market trends
and provides forecast from 2019-2025. We also have highlighted future trends in
the market that will affect the demand during the forecast period. Moreover,
the competitive analysis given in each regional market brings an insight into
the market share of the leading players.